Similar regulation of cell surface human T-cell leukemia virus type 1 (HTLV-1) surface binding proteins in cells highly and poorly transduced by HTLV-1-pseudotyped virions

Journal of Virology

Volumn 76, Issue 24, 2002, Pages 12723-12734

  Jones, Kathryn S ^a   Nath, Manisha ^b   Petrow Sadowski, Cari ^a   Baines, Andrea C ^b   Dambach, Megan ^b   Huang, Ying ^b   Ruscetti, Francis W ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CD4 ANTIGEN; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; INFECTION SENSITIVITY; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RETROVIRUS; RODENT; SPECIES DIFFERENCE; VIRION; VIRUS ADSORPTION; VIRUS LOAD;

3T3 CELLS; ANIMALS; HELA CELLS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOGLOBULIN G; MICE; RECEPTORS, VIRUS; TETRADECANOYLPHORBOL ACETATE; TRANSDUCTION, GENETIC; VIRAL ENVELOPE PROTEINS; VIRION;

EID: 0036893182     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.24.12723-12734.2002     Document Type: Article

References (78)

1. Adkins, H. B., J. Brojatsch, J. Naughton, M. M. Rolls, J. M. Pesola, and J. A. Young. 1997. Identification of a cellular receptor for subgroup E avian leukosis virus. Proc. Natl. Acad. Sci. USA 94:11617-11622.
2. Brojatsch, J., J. Naughton, M. M. Rolls, K. Zingler, and J. A. Young. 1996. CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis. Cell 87:845-855.
3. Byrn, R. A., J. Mordenti, C. Lucas, D. Smith, S. A. Marsters, J. S. Johnson, P. Cossum, S. M. Chamow, F. M. Wurm, T. Gregory, et al. 1990. Biological properties of a CD4 immunoadhesin. Nature 344:667-670.
4. Capon, D. J., S. M. Chamow, J. Mordenti, S. A. Marsters, T. Gregory, H. Mitsuya, R. A. Byrn, C. Lucas, F. M. Wurm, J. E. Groopman, et al. 1989. Designing CD4 immunoadhesins for AIDS therapy. Nature 337:525-531.
5. Center, R. J., B. Kobe, K. A. Wilson, T. Teh, G. J. Howlett, B. E. Kemp, and P. Poumbourios. 1998. Crystallization of a trimeric human T cell leukemia virus type 1 gp21 ectodomain fragment as a chimera with maltose-binding protein. Protein Sci. 7:1612-1619.
6. Clapham, P., K. Nagy, R. Cheingsong-Popov, M. Exley, and R. A. Weiss. 1983. Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line. Science 222:1125-1127.
7. Clapham, P. R., and A. McKnight. 2001. HIV-1 receptors and cell tropism. Br. Med. Bull. 58:43-59.
8. Coelen, R. J., D. G. Jose, and J. T. May. 1983. The effect of hexadimethrine bromide (polybrene) on the infection of the primate retroviruses SSV 1/SSAV 1 and BaEV. Arch. Virol. 75:307-311.
9. Daenke, S., and S. Booth. 2000. HTLV-1-induced cell fusion is limited at two distinct steps in the fusion pathway after receptor binding. J. Cell Sci. 113: 37-44.
10. Daenke, S., and S. Booth. 2000. Molecular mechanisms affecting HTLV type 1-dependent fusion at the cell membrane: Implications for inhibiting viral transmission. AIDS Res. Hum. Retrovir. 16:1731-1736.
11. Delamarre, L., A. R. Rosenberg, C. Pique, D. Pham, and M. C. Dokhelar. 1997. A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity. J. Virol. 71:259-266.
12. Derse, D., J. Mikovits, D. Waters, S. Brining, and F. Ruscetti. 1996. Examining the molecular genetics of HTLV-I with an infectious molecular clone of the virus and permissive cell culture systems. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12:1-5.
13. Dirks, C., and A. D. Miller. 2001. Many nonmammalian cells exhibit postentry blocks to transduction by gammaretroviruses pseudotyped with various viral envelopes, including vesicular stomatitis virus G glycoprotein. J. Virol. 75:6375-6383.
14. Doms, R. W. 2000 Beyond receptor expression: the influence of receptor conformation, density and affinity in HIV-1 infection. Virology 276:229-237.
15. Eiden, M. V., K. Farrell, and C. A. Wilson. 1994. Glycosylation-dependent inactivation of the ecotropic murine leukemia virus receptor. J. Virol. 68: 626-631.
16. Forster, R., E. Kremmer, A. Schubel, D. Breitfeld, A. Kleinschmidt, C. Nerl, G. Bernhardt, and M. Lipp. 1998. Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsets: Rapid internalization and recycling upon activation. J. Immunol. 160:1522-1531.
17. Gavalchin, J., N. Fan, M. J. Lane, L. Papsidero, and B. J. Poiesz. 1993. Identification of a putative cellular receptor for HTLV-I by a monoclonal antibody, Mab 34-23. Virology 194:1-9.
18. Gavalchin, J., N. Fan, P. G. Waterbury, E. Corbett, B. D. Faldasz, S. M. Peshick, B. J. Poiesz, L. Papsidero, and M. J. Lane. 1995. Regional localization of the putative cell surface receptor for HTLV-I to human chromosome 17q23.2-17q25.3. Virology 212:196-203.
19. Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. de The. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii:407-410.
20. Hadlock, K. G., J. Rowe, S. Perkins, P. Bradshaw, G. Y. Song, C. Cheng, J. Yang, R. Gascon, J. Halmos, S. M. Rehman, M. S. McGrath, and S. K. Foung. 1997. Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46. J. Virol. 71:5828-5840.
21. Hadlock, K. G., J. Rowe, and S. K. H. Foung. 1999. The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes. J. Virol. 72:1205-1212.
22. Han, J. Y., Y. Zhao, W. F. Anderson, and P. M. Cannon. 1998. Role of variable regions A and B in receptor binding domain of amphotropic murine leukemia virus envelope protein. J. Virol. 72:9101-9108.
23. Haraguchi, Y., Y. Takeuchi, and H. Hoshino. 1997. Inhibition of plating of human T cell leukemia virus type I and syncytium-inducing types of human immunodeficiency virus type 1 by polycations. AIDS Res. Hum. Retrovir. 13:1517-1523.
24. Hildreth, J. E. 1998. Syncytium-inhibiting monoclonal antibodies produced against human T-cell lymphotropic virus type 1-infected cells recognize class II major histocompatibility complex molecules and block by protein crowding. J. Virol. 71:9544-9552.
25. Holmen, S. L., and M. J. Federspiel. 2000. Selection of a subgroup A avian leukosis virus [ALV(A)] envelope resistant to soluble ALV(A) surface glycoprotein. Virology 273:364-373.
26. Hoxie, J. A., J. L. Rackowski, B. S. Haggarty, and G. N. Gaulton. 1988. T4 endocytosis and phosphorylation induced by phorbol esters but not by mitogen or HIV infection. J. Immunol. 140:786-795.
27. Jassal, S. R., R. G. Pohler, and D. W. Brighty. 2001. Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin. J. Virol. 75:8317-8328.
28. Jinno, A., T. Haraguchi, H. Shiraki, and H. Hoshino. 1999. Inhibition of cell-free human T-cell leukemia virus type 1 infection at a postbinding step by the synthetic peptide derived from an ectodomain of the gp21 transmembrane glycoprotein. J. Virol. 73:9683-9689.
29. Kim, F. J., I. Seiliez, C. Denesvre, D. Lavillette, F. L. Cosset, and M. Sitbon. 2000. Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fusogenic range of an ecotropic murine leukemia virus. J. Biol. Chem. 275:23417-23420.
30. Koyanagi, Y., Y. Itoyama, N. Nakamura, K. Takamatsu, J. Kira, T. Iwamasa, I. Goto, and N. Yamamoto. 1993. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 196:25-33.
31. Krichbaum-Stenger, K., B. J. Poeisz, P. Keller, G. Ehrlich, J. Gavalchin, B. H. Davis, and J. L. Moore. 1987. Specific adsorption of HTLV-I to various target human and animal cells. Blood 70:1303-1311.
32. Kuhmann, S. E., E. Platt, S. L. Kozak, and D. Kabat. 2000. Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1. J. Virol. 74:7005-7015.
33. Kurre, P., H.-P. Kiem, J. Morris, S. Heyward, J.-L. Battini, and A. D. Miller. 1999. Efficient transduction by an amphotropic retrovirus vector is dependent on high-level expression of the cell surface virus receptor. J. Virol. 73:495-500.
34. P. Kurre, J. Morris, A. D. Miller, and H.-P. Kiem. 2001. Envelope fusion protein binding studies in an inducible model of retrovirus receptor expression and in CD34+ cells emphasize limited transduction at low receptor levels. Gene Ther. 8:593-599.
35. Li, Q. X., D. Camerini, Y. Xie, M. Greenwald, D. R. Kuritzkes, and I. S. Chen. 1996. Syncytium formation by recombinant HTLV-II envelope glycoprotein. Virology 218:279-284.
36. MacDonald, C., S. Walker, M. Watts, S. Ings, D. C. Linch, and S. Devereux. 2000. Effect of changes in expression of the amphotropic retroviral receptor PiT-2 on transduction efficiency and viral titer: Implications for gene therapy. Hum. Gene Ther. 11:587-595.
37. Maerz, A. L., R. J. Center, B. E. Kemp, B. Kobe, and P. Poumbourios. 2000. Functional implications of the human T-lymphotropic virus type 1 transmembrane glycoprotein helical hairpin structure. J. Virol. 74:6614-6621.
38. Manning, J. S., A. J. Hackett, and N. B. Darby, Jr. 1971. Effect of polycations on sensitivity of BALB-3T3 cells to murine leukemia and sarcoma virus infectivity. Appl. Microbiol. 22:1162-1163.
39. Miller, D. G., and A. D. Miller. 1992. Tunicamycin treatment of CHO cells abrogates multiple blocks to retrovirus infection, one of which is due to a secreted inhibitor. J. Virol. 66:78-84.
40. Miller, D. G., and A. D. Miller. 1993. Inhibitors of retrovirus infection are secreted by several hamster cell lines and are also present in hamster sera. J. Virol. 67:5346-5352.
41. Miyoshi, I., I. Kubonishi, S. Yoshimoto, T. Akagi, Y. Ohtsuki, Y. Shiraishi, K. Nagata, and Y. Hinuma. 1981. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells, Nature 294:770-771.
42. Nagai, M., B. Brennan, J. Sakai, C. A. Carlos, and S. Jacobson. 2001. CD8+ T cells are an in vivo reservoir for human T-cell lymphotropic virus type 1. Blood 98:1858-1861.
43. Nagy, K., P. Clapham, R. Cheingsong-Popov, and R. A. Weiss. 1983. Human T-cell leukemia virus type I: Induction of syncytia and inhibition by patients' sera. Int. J. Cancer 32:321-328.
44. Niyogi, K., and J. E. Hildreth. 2001. Characterization of new syncytium-inhibiting monoclonal antibodies implicates lipid rafts in human T-cell leukemia virus type 1 syncytium formation. J. Virol. 75:7351-7361.
45. O'Doherty, U., W. J. Swiggard, and M. H. Malim. 2000. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 74:10074-10080.
46. Okuma, K., Y. Matsuura, H. Tatsuo, Y. Inagaki, M. Nakamura, N. Yamamoto, and Y. Yanagi. 2001. Analysis of the molecules involved in human T-cell leukaemia virus type 1 entry by a vesicular stomatitis virus pseudotype bearing its envelope glycoproteins. J. Gen. Virol. 82:821-830.
47. Okuma, K., M. Nakamura, S. Nakano, Y. Niho, and Y. Matsuura. 1999. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay. Virology 254:235-244.
48. Osame, M., S. Izumo, A. Igata, M. Matsumoto, T. Matsumoto, S. Sonoda, M. Tara, and Y. Shibata. 1986. Blood transfusion and HTLV-I associated myelopathy. Lancet ii:104-105.
49. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
50. Pelchen-Matthews, A., I. J. Parsons, and M. Marsh. 1993. Phorbol ester-induced down-regulation of CD4 is a multistep process involving dissociation from p561ck, increased association with clathrin-coated pits, and altered endosomal sorting. J. Exp. Med. 178:1209-1222.
51. Pique, C., D. Pham, T. Tursz, and M. C. Dokhelar. 1993. The cytoplasmic domain of the human T-cell leukemia virus type I envelope can modulate envelope functions in a cell type-dependent manner. J. Virol. 67:557-561.
52. Poiesz, B. J., L. D. Papsidero, G. Ehrlich, M. Sherman, S. Dube, M. Poiesz, K. Dillon, F. W. Ruscetti, D. Slamon, C. Fang, A. Williams, D. Duggan, J. Glaser, A. Gottlieb, J. Goldberg, L. Ratner, P. Phillips, T. Han, A. Friedman-Kien, F. Siegal, K. Rai, A. Sawitsky, L. W. Sheremata, H. Dosik, and R. Montagna. 2001. Prevalence of HTLV-I-associated T-cell lymphoma. Am. J. Hematol. 66:32-38.
53. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415-7419.
54. Richardson, J. H., A. J. Edwards, J. K. Cruickshank, P. Rudge, and A. G. Dalgleish. 1990. In vivo cellular tropism of human T-cell leukemia virus type 1. J. Virol. 64:5682-5687.
55. Rosenberg, A. R., L. Delamarre, C. Pique, D. Pham, and M. C. Dokhelar. 1997. The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events. J. Virol. 71:7180-7186.
56. Rosenberg, A. R., L. Delamarre, A. Preira, and M. C. Dokhelar. 1998. Analysis of functional conservation in the surface and transmembrane glycoprotein subunits of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2. J. Virol. 72:7609-7614.
57. Sagara, Y., Y. Inoue, E. Kojima, C. Ishida, H. Shiraki, and Y. Maeda. 2001. Phosphatidylglycerol participates in syncytium formation induced by HTLV type 1-bearing cells. AIDS Res. Hum. Retrovir. 17:125-135.
58. Sagara, Y., C. Ishida, Y. Inoue, H. Shiraki, and Y. Maeda. 1997. Trypsinsensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells. J. Virol. 71:601-607.
59. Seiki, M., S. Hattori, and M. Yoshida. 1982. Human adult T-cell leukemia virus: Molecular cloning of the provirus DNA and the unique terminal structure. Proc. Natl. Acad. Sci. USA 79:6899-6902.
60. Signoret, N., J. Oldridge, A. Pelchen-Matthews, P. J. Klasse, T. Tran, L. F. Brass, M. M. Rosenkilde, T. W. Schwartz, W. Holmes, W. Dallas, M. A. Luther, T. N. Wells, J. A. Hoxie, and M. Marsh. 1997. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J. Cell Biol. 139:651-664.
61. Sinangil, F., S. Harada, D. T. Purtilo, and D. J. Volsky. 1985. Host cell range of adult T-cell leukemia virus. I. Viral infectivity and binding to various cells as detected by flow cytometry. Int. J. Cancer 36:191-198.
62. Snitkovsky, S., T. M. Niederman, B. S. Carter, R. C. Mulligan, and J. A. Young. 2000. A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor. J. Virol. 74:9540-9545.
63. Sommerfelt, M. A. 1999. Retrovirus receptors. J. Gen. Virol. 80:3049-3064.
64. Sommerfelt, M. A., and R. A. Weiss. 1990. Receptor interference groups of 20 retroviruses plating on human cells. Virology 176:58-69.
65. Sommerfelt, M. A., B. P. Williams, P. R. Clapham, E. Solomon, P. N. Goodfellow, and R. A. Weiss. 1988. Human T cell leukemia viruses use a receptor determined by human chromosome 17. Science 242:1557-1559.
66. Soneoka, Y., P. M. Cannon, E. E. Ramsdale, J. C. Griffiths, G. Romano, S. M. Kingsman, and A. J. Kingsman. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:628-633.
67. Sutton, R. E., and D. R. Littman. 1996. Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J. Virol. 70:7322-7326.
68. Tahara-Hanaoka, S., Y. Ushijima, H. Tarui, M. Wada, T. Hara, S. Imanishi, T. Yamaguchi, T. Hattori, H. Nakauchi, and A. Koito. 2000. Differential level in co-down-modulation of CD4 and CXCR4 primed by HIV-1 gp12O in response to phorbol ester, PMA, among HIV-1 isolates. Microbiol. Immunol. 44:489-498.
69. Tailor, C. S., A. Nouri, and D. Kabat. 2000. Cellular and species resistance to murine amphotropic, gibbon ape, and feline subgroup C leukemia viruses is strongly influenced by receptor expression levels and by receptor masking mechanisms. J. Virol. 74:9797-9801.
70. Talbot, S. J., R. A. Weiss, and T. F. Schulz. 1995. Reduced glycosylation of human cell lines increases susceptibility to CD4-independent infection by human immunodeficiency virus type 2 (LAV-2/B). J. Virol. 69:3399-3406.
71. Tavoloni, N., and A. Rudenholz. 1997. Variable transduction efficiency of murine leukemia retroviral vector on mammalian cells: Role of cellular glycosylation. Virology 229:49-56.
72. Toyoshima, K., and P. K. Vogt. 1969. Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions. Virology 38:414-426.
73. Trejo, S. R., and L. Ratner. 2000. The HTLV receptor is a widely expressed protein. Virology 268:41-48.
74. Vile, R. G., T. F. Schulz, O. F. Danos, M. K. Collins, and R. A. Weiss. 1991. A murine cell line producing HTLV-I pseudotype virions carrying a selectable marker gene. Virology 180:420-424.
75. Wilson, C., M. S. Reitz, H. Okayama, and M. V. Eiden. 1989. Formation of infectious hybrid virions with gibbon ape leukemia virus and human T-cell leukemia virus retroviral envelope glycoproteins and the gag and pol proteins of Moloney murine leukemia virus. J. Virol. 63:2374-2378.
76. Yamamoto, N., T. Chosa, Y. Koyanagi, T. Tochikura, J. Schneider, and Y. Hinuma. 1984. Binding of adult T-cell leukemia virus to various hematopoietic cells. Cancer Lett. 21:261-268.
77. Yoshida, M., I. Miyoshi, and Y. Hinuma. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA 79:2031-2035.
78. Zingler, K., and J. A. Young. 1996. Residue Trp-48 of Tva is critical for viral entry but not for high-affinity binding to the SU glycoprotein of subgroup A avian leukosis and sarcoma viruses. J. Virol. 70:7510-7516.